NFL Biosciences is a pioneering biotechnology company focused on developing innovative solutions for addiction withdrawal. With a core focus on smoking cessation, our mission is to help smokers win their battle for a healthier life. Our flagship product, NFL-101, is currently in Phase II clinical trials and offers a breakthrough approach to curing smoking addiction.

It is a botanical drug derived from natural tobacco leaf proteins, containing an insignificant amount of nicotine. Our team of leading scientists and entrepreneurs have come together to revolutionize addiction treatment and bring a next-level cure to this deadly addiction. At NFL Biosciences, we combine cutting-edge research with a deep understanding of the challenges faced by individuals trying to quit smoking.

We are driven by a commitment to improve lives and make a significant impact on public health. Join us on this transformative journey towards a smoke-free future